Q3 2019
Released Nov 6, 2019, before the open
10-Q filed Nov 6, 2019, 37 days after period end · 0001493152-19-016513
Q3 2019 · 10-Q
Revenue$3.10M$3.10M +79.5% vs Q3 2018+34.0% vs Q2 2019
Net Income-$744.00K-$744.00K N/M vs Q3 2018N/M vs Q2 2019
EPS Diluted-$0.10-$0.10 N/M vs Q3 2018N/M vs Q2 2019
Gross Profit$1,819,000+91.1%
Operating Income-$695,000N/M
Operating Cash Flowderived-$614,000N/M
Margins · derived
Gross margin58.8%+3.6 pt vs Q3 2018
Operating margin-22.5%+7.2 pt vs Q3 2018
Net margin-24.0%+8.8 pt vs Q3 2018
What the release said
The release
Same quarter
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $3.10M | $1.72M | $916.00K | $475.00K |
| Net Income | -$744.00K | -$566.00K | -$632.00K | -$706.00K |
| EPS Diluted | -$0.10 | -$0.08 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR